Clinical Trials Browser

Phase 2 × Completed × Adenocarcinoma, Clear Cell × Clear all

NCT03241745 2024-12-27

A Study of Nivolumab in Selected Uterine Cancer Patients

Phase 2 Completed

35 enrolled 8 charts

GynecologicSarcoma

Carcinosarcoma, Leiomyosarcoma, Uterine Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT00563784 2019-11-20

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

68 enrolled 11 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Adenocarcinoma, Clear Cell, Carcinoma, Giant Cell

NCT01824615 2018-07-18

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Phase 2 Completed

Ovarian Neoplasms, Adenocarcinoma, Clear Cell

NCT00455975 2014-12-22

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Phase 2 Completed

119 enrolled 8 charts

Kidney Neoplasms, Adenocarcinoma, Clear Cell